Log in

goodpods headphones icon

To access all our features

Open the Goodpods app
Close icon
OIS Podcast | Ophthalmology's leading Podcast - Digital Health Is Dead? Don’t Tell Mark Blumenkranz, the FDA, or the Organizers of an Oct. Workshop

Digital Health Is Dead? Don’t Tell Mark Blumenkranz, the FDA, or the Organizers of an Oct. Workshop

09/13/17 • 37 min

OIS Podcast | Ophthalmology's leading Podcast
Accomplished ophthalmologist Mark Blumenkranz, MD, moved early into the Digital Health space by co-founding Digisight, one of the more advanced efforts in ophthalmology. Six years, later, Dr. Blumenkranz still sees enormous opportunity so he’s working with the FDA and top clinical societies to hold a one-day workshop for physicians, investors, and entrepreneurs interested in learning how Digital Health fits into ophthalmology.
plus icon
bookmark
Accomplished ophthalmologist Mark Blumenkranz, MD, moved early into the Digital Health space by co-founding Digisight, one of the more advanced efforts in ophthalmology. Six years, later, Dr. Blumenkranz still sees enormous opportunity so he’s working with the FDA and top clinical societies to hold a one-day workshop for physicians, investors, and entrepreneurs interested in learning how Digital Health fits into ophthalmology.

Previous Episode

undefined - What Was the Most Difficult Part of Successfully Transitioning to CMO? We Ask B&L’s Cal Roberts

What Was the Most Difficult Part of Successfully Transitioning to CMO? We Ask B&L’s Cal Roberts

In 2011, Cal Roberts, MD, got an unexpected call from Brent Saunders, then head of Bausch & Lomb. Saunders asked if Dr. Roberts would trade a thriving ophthalmology practice to serve as chief medical officer at the eye care giant. Today, Dr. Roberts is thrilled with the decision, and other ophthalmology companies are following the example, bringing on practicing physicians as CMOs. But what were Dr. Roberts’ concerns? And why did he decide to take the leap? “It’s difficult and it’s sometimes more difficult than someone coming in realizes,” he says.

Next Episode

undefined - Hatteras’ Shaffer Found a Model That Works at Inspire; Now She Uses It When Making Investments

Hatteras’ Shaffer Found a Model That Works at Inspire; Now She Uses It When Making Investments

Christy Shaffer, PhD, general partner at Hatteras Venture Partners, didn’t have a career map that led her into the corner office at Inspire Pharmaceuticals or into the partnership at Hatteras Venture Partners. But the clinical scientist grew to succeed in both roles. Dr. Shaffer led Inspire when the company conceived and then built out its ophthalmology program, a business that trained many of today’s ophthalmology leaders. That experience still serves her today as she funds entrepreneurs and start-ups inside and outside of ophthalmology.

Episode Comments

Generate a badge

Get a badge for your website that links back to this episode

Select type & size
Open dropdown icon
share badge image

<a href="https://goodpods.com/podcasts/ois-podcast-ophthalmologys-leading-podcast-412060/digital-health-is-dead-dont-tell-mark-blumenkranz-the-fda-or-the-organ-57417259"> <img src="https://storage.googleapis.com/goodpods-images-bucket/badges/generic-badge-1.svg" alt="listen to digital health is dead? don’t tell mark blumenkranz, the fda, or the organizers of an oct. workshop on goodpods" style="width: 225px" /> </a>

Copy